Drugs.com

FEBRUARY 3, 2024

SATURDAY, Feb. 3, 2024 -- Driving at night can be risky business, as a dangerous combination of darkness and the glare of bright lights can make it hard to see the road, but one expert offers some safety tips.“If you have to drive in the evening.

105

105

Drug Patent Watch

FEBRUARY 3, 2024

NATESTO (testosterone) Acerus Patent: 8,877,230 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of February 4, 2024 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 64

Drugs Pharmaceuticals 64

Drug Patent Watch

FEBRUARY 3, 2024

Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting… The post New patent expiration for Acerus drug NATESTO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

FEBRUARY 3, 2024

This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Portugal? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 59

Pharmaceuticals Drugs 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Patent Watch

FEBRUARY 3, 2024

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent expiration for Sumitomo Pharma drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59